aztreonam has been researched along with Wounds, Penetrating in 1 studies
Aztreonam: A monocyclic beta-lactam antibiotic originally isolated from Chromobacterium violaceum. It is resistant to beta-lactamases and is used in gram-negative infections, especially of the meninges, bladder, and kidneys. It may cause a superinfection with gram-positive organisms.
aztreonam : A synthetic monocyclic beta-lactam antibiotic (monobactam), used primarily to treat infections caused by Gram-negative bacteria. It inhibits mucopeptide synthesis in the bacterial cell wall, thereby blocking peptidoglycan crosslinking.
Wounds, Penetrating: Wounds caused by objects penetrating the skin.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Aztreonam was administered at a dosage of 2 g every 8 hours and gentamicin at 5 mg/kg for the first 24 hours and then adjusted by serum monitoring to a peak of 6 to 8 micrograms/mL and a trough of less than 2 micrograms/mL; all patients received 900 mg of clindamycin every 8 hours." | 2.67 | Superiority of aztreonam/clindamycin compared with gentamicin/clindamycin in patients with penetrating abdominal trauma. ( Boucher, BA; Charland, SL; Croce, MA; Fabian, TC; Hess, MM; Rodman, JH; Wilson, RS; Wilson, SE, 1994) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fabian, TC | 1 |
| Hess, MM | 1 |
| Croce, MA | 1 |
| Wilson, RS | 1 |
| Wilson, SE | 1 |
| Charland, SL | 1 |
| Rodman, JH | 1 |
| Boucher, BA | 1 |
1 trial available for aztreonam and Wounds, Penetrating
| Article | Year |
|---|---|
Superiority of aztreonam/clindamycin compared with gentamicin/clindamycin in patients with penetrating abdominal trauma.
Topics: Abdominal Injuries; Adult; Aztreonam; Bacterial Infections; Blood Transfusion; Clindamycin; Colon; D | 1994 |